Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucinous Cystadenocarcinoma of the Breast: A Clinicopathologic and Molecular Case Report With Literature Review.

International journal of surgical pathology·2026
Same author

A deep learning framework for efficient pathology image analysis.

Nature communications·2026
Same author

Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study.

Cancers·2026
Same author

Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Pathologica·2026
Same author

Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.

Pathologica·2026
Same author

<i>PIK3CA</i> testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs.

Pathologica·2026

Related Experiment Video

Updated: Oct 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K

Special Issue: Molecular Biomarkers in Solid Tumors.

Nicola Fusco1,2, Caterina Marchiò3,4, Michele Ghidini5

  • 1Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.

Genes
|July 2, 2021
PubMed
Summary

Next-generation diagnostic strategies offer a systematic approach to significantly improve cancer patient outcomes and quality of life. This advanced method promises better results for individuals battling cancer.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.7K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K

Related Experiment Videos

Last Updated: Oct 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.7K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Current cancer diagnostics face limitations in early detection and personalized treatment.
  • The emergence of next-generation sequencing (NGS) provides unprecedented molecular insights.

Discussion:

  • Systematic application of NGS-based diagnostics can identify actionable mutations.
  • Integrating multi-omic data enhances diagnostic accuracy and prognostic prediction.
  • This approach facilitates tailored therapeutic strategies, moving beyond one-size-fits-all treatments.

Key Insights:

  • Next-generation diagnostic strategies represent a paradigm shift in cancer care.
  • Early and accurate molecular profiling is crucial for effective cancer management.
  • Personalized treatment selection based on comprehensive genomic data improves patient outcomes.

Outlook:

  • Wider adoption of these advanced diagnostic tools is expected.
  • Continued research will refine systematic approaches for broader applicability.
  • The ultimate goal is to enhance survival rates and improve the quality of life for cancer patients.